RecallRadar

FDA Drug recall D-0305-2026

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufac…

On 2026-02-11 the FDA classified a Class II recall of Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufac… by Granules Pharmaceuticals, citing presence of Foreign Tablets/Capsules.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0305-2026
ClassificationClass II
Statusongoing
Initiated2026-01-26
Published2026-02-11
Last updated2026-09-13 11:52 UTC
CompanyGranules Pharmaceuticals
DistributionUS

Product

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Reason

Presence of Foreign Tablets/Capsules

Identifiers

ndc70010-231-03
ndc70010-231-01
ndc70010-231-05
ndc70010-231-10
ndc70010-232-03
ndc70010-232-01
ndc70010-232-05
ndc70010-232-10
ndc70010-233-03
ndc70010-233-01
ndc70010-233-05
ndc70010-234-03
ndc70010-234-01
ndc70010-234-05
code_infoBatch # 6160008A, Exp Date: 12/31/2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0305-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.